You are currently viewing a new version of our website. To view the old version click .

New Insights into Antimicrobial Drug Discovery

This special issue belongs to the section “Medicinal Chemistry“.

Special Issue Information

Dear Colleagues,

It is undeniable that antimicrobial resistance (AMR) is an emergent health problem so dire that it can potentially lead to a ‘post-antibiotic’ era, marked by the end of effective antibiotics. The World Health Organization (WHO) has already defined AMR as a serious threat to global public health, with estimates that AMR is responsible for over 700,000 deaths annually around the world. Despite the increased awareness, the clinical antibacterial pipeline remains insufficient, and there is a pressing and unmet need for innovative antimicrobial drugs.

New chemical entities to tackle AMR are limited, and exploring new scaffolds to achieve new and better outcomes is urgently needed. This proposed Special Issue will provide a platform for researchers to publish their recent findings and perspectives in the design, synthesis, and identification of new antimicrobial agents. High-quality reviews in the field will also be accepted.

Prof. Dr. Fernanda Borges
Dr. Alexandra Gaspar
Dr. Fernando Cagide Fagin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobials
  • antimicrobial resistance
  • drug discovery
  • antimicrobial mechanism of action
  • innovative scaffolds
  • cinnamic acids and derivatives
  • benzoic acids and derivatives
  • chromones and analogues
  • coumarins and analogues
  • quinones and analogues
  • quinolones and analogues
  • oxazolidinones and analogues
  • ionic liquids and analogues
  • nanosystems/nanomaterials
  • peptides/glycopeptides
  • phytochemicals
  • miscellaneous

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Molecules - ISSN 1420-3049